Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Paracelsian Inc (PRLN) -- Ignore unavailable to you. Want to Upgrade?

To: paul goldstein who wrote (3639)	5/20/1998 10:11:00 AM
From: Harold Stone	Read Replies (1) \| Respond to of 4342

Paul, Just for more conversation.. I think we could agree that the best solution for the company is to get the stock above 1.00 and keep it there. If we just get to a 1.00 we still have the threat of a reverse split In my post to Jonathan I did not mean to imply that the NASDAQ was lax in regulating the small caps and /or delisting of companies that did not have a bon-a -fide plan or were not showing any progress towards accomplishing it. I meant that it is my belief that NASDAQ will work with a company as long as they feel there is a good chance for a company to meet the requirements to remain listed. A 3 for 1 reverse split would undoubtedly be the next move to avoid delisting. Since there hasn't been any recent news other than "Natures Way" letter of intent I would expect that the next news we can get will be that there is an agreement between between the two companies and that they will be using the BioFit certification on the packaging. Till next time, Harold